200 related articles for article (PubMed ID: 27923198)
1. Detoxification with titration and tapering in gamma-hydroxybutyrate (GHB) dependent patients: The Dutch GHB monitor project.
Dijkstra BA; Kamal R; van Noorden MS; de Haan H; Loonen AJ; De Jong CA
Drug Alcohol Depend; 2017 Jan; 170():164-173. PubMed ID: 27923198
[TBL] [Abstract][Full Text] [Related]
2. Gamma-hydroxybutyrate detoxification by titration and tapering.
de Jong CA; Kamal R; Dijkstra BA; de Haan HA
Eur Addict Res; 2012; 18(1):40-5. PubMed ID: 22142784
[TBL] [Abstract][Full Text] [Related]
3. [Detoxification of patients with GHB dependence].
de Weert-van Oene GH; Schellekens AF; Dijkstra BA; Kamal R; de Jong CA
Tijdschr Psychiatr; 2013; 55(11):885-90. PubMed ID: 24242149
[TBL] [Abstract][Full Text] [Related]
4. Tapering with Pharmaceutical GHB or Benzodiazepines for Detoxification in GHB-Dependent Patients: A Matched-Subject Observational Study of Treatment-as-Usual in Belgium and The Netherlands.
Beurmanjer H; Luykx JJ; De Wilde B; van Rompaey K; Buwalda VJA; De Jong CAJ; Dijkstra BAG; Schellekens AFA
CNS Drugs; 2020 Jun; 34(6):651-659. PubMed ID: 32319006
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of gamma-hydroxybutyrate withdrawal].
Strand NAW; Petersen TS; Nielsen LM; Boegevig S
Ugeskr Laeger; 2017 Dec; 179(50):. PubMed ID: 29260701
[TBL] [Abstract][Full Text] [Related]
6. Baclofen as relapse prevention in the treatment of Gamma- Hydroxybutyrate (GHB) dependence: an open label study.
Kamal RM; Schellekens A; De Jong CA; Dijkstra BA
BMC Psychiatry; 2015 Apr; 15():91. PubMed ID: 25927622
[TBL] [Abstract][Full Text] [Related]
7. Sodium Oxybate Therapy for Alcohol Withdrawal Syndrome and Keeping of Alcohol Abstinence.
Mannucci C; Pichini S; Spagnolo EV; Calapai F; Gangemi S; Navarra M; Calapai G
Curr Drug Metab; 2018; 19(13):1056-1064. PubMed ID: 29219048
[TBL] [Abstract][Full Text] [Related]
8. [Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment].
van Noorden MS; Kamal R; de Jong CA; Vergouwen AC; Zitman FG
Ned Tijdschr Geneeskd; 2010; 154():A1286. PubMed ID: 21040601
[TBL] [Abstract][Full Text] [Related]
9. The Neurobiological Mechanisms of Gamma-Hydroxybutyrate Dependence and Withdrawal and Their Clinical Relevance: A Review.
Kamal RM; van Noorden MS; Franzek E; Dijkstra BA; Loonen AJ; De Jong CA
Neuropsychobiology; 2016; 73(2):65-80. PubMed ID: 27003176
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention.
Kamal RM; van Noorden MS; Wannet W; Beurmanjer H; Dijkstra BA; Schellekens A
CNS Drugs; 2017 Jan; 31(1):51-64. PubMed ID: 28004314
[TBL] [Abstract][Full Text] [Related]
11. Inpatient Gamma-Hydroxybutyrate Detoxification: A Case Report Describing Day-to-day Therapeutic Management.
von Theobald L; Rousselet M; Cholet J; Debar H; Boels D; Victorri-Vigneau C; Grall-Bronnec M
J Addict Med; 2017; 11(3):231-234. PubMed ID: 28125446
[TBL] [Abstract][Full Text] [Related]
12. Baclofen to Prevent Relapse in Gamma-Hydroxybutyrate (GHB)-Dependent Patients: A Multicentre, Open-Label, Non-Randomized, Controlled Trial.
Beurmanjer H; Kamal RM; de Jong CAJ; Dijkstra BAG; Schellekens AFA
CNS Drugs; 2018 May; 32(5):437-442. PubMed ID: 29651711
[TBL] [Abstract][Full Text] [Related]
13. Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses.
Leone MA; Vigna-Taglianti F; Avanzi G; Brambilla R; Faggiano F
Cochrane Database Syst Rev; 2010 Feb; (2):CD006266. PubMed ID: 20166080
[TBL] [Abstract][Full Text] [Related]
14. The gamma-hydroxybutyrate withdrawal syndrome.
Tarabar AF; Nelson LS
Toxicol Rev; 2004; 23(1):45-9. PubMed ID: 15298492
[TBL] [Abstract][Full Text] [Related]
15. [GHB withdrawal delirium].
Stijnenbosch PJ; Zuketto C; Beijaert PJ; Maat A
Ned Tijdschr Geneeskd; 2010; 154():A1086. PubMed ID: 20132572
[TBL] [Abstract][Full Text] [Related]
16. Clinical management of gamma-hydroxybutyrate (GHB) withdrawal delirium with CIWA-Ar protocol.
Liao PC; Chang HM; Chen LY
J Formos Med Assoc; 2018 Dec; 117(12):1124-1127. PubMed ID: 29933901
[TBL] [Abstract][Full Text] [Related]
17. A case series of pharmaceutical gamma-hydroxybutyrate in 3 patients with severe benzodiazepine-resistant gamma-hydroxybutyrate withdrawal in the hospital.
van Noorden MS; Kamal RM; Dijkstra BA; Mauritz R; de Jong CA
Psychosomatics; 2015; 56(4):404-9. PubMed ID: 25016356
[No Abstract] [Full Text] [Related]
18. [Course and complications of GHB detoxification treatment: a 1-year case series].
Neu P
Nervenarzt; 2019 May; 90(5):509-515. PubMed ID: 30362026
[TBL] [Abstract][Full Text] [Related]
19. [Withdrawal syndrome following chronic use of gamma-hydroxybutyric acid (GHB)].
Moitroux A; Kestens C
Rev Med Liege; 2023 Jul; 78(7-8):451-455. PubMed ID: 37560960
[TBL] [Abstract][Full Text] [Related]
20. [Hypernatremia caused by treatment with GHB obtained via a doctor's prescription].
Rood IM; Seijger CG; van Waarde JA; de Maat MM; Verhave JC; Blans MJ
Tijdschr Psychiatr; 2017; 59(1):47-51. PubMed ID: 28098924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
